Honey is an ancient treatment that is increasingly earning its place in modern wound care, antibacterial properties, ease of use and ability to promote a moist environment there have been advances in the selection of honey for use in wound care, based on its antibacterial properties, and in clinical protocols for its use. This paper examines wound-healing results achieved with honey in the past two years, the extent of its use and practical issues relating to its clinical use. In honey the activity is due to hydrogen peroxide, but much of this is inactivated by the enzyme catalase that is present in blood, serum, and wound tissues. Hydrogen peroxide in honey is 1000 times more potent than in regular hydrogen peroxide available commercially. The aim of this study is to establish if honey is a reliable substitute for dressings of traumatic wounds instead of use of regular dressing materials. This prospective longitudinal study has been done in department of orthopedics, Pravara rural hospital, rural medical college, Loni, tal-Rahata, dist-Ahmednagar.
Globally, traumatic injuries of long bones shaft fractures in children are the most leading causes of fractures in children. Now a days the use of elastic stable intra-medullary nails has dramatically increased with the introduction of a variety of nails for paediatric fractures [1] . The Titanium Elastic Nail (TEN) is intended for fixation of diaphyseal fractures of long bones where the medullary canal is narrow or flexibility of the implant is paramount. The aim of this study of biological, minimally invasive fracture treatment is to achieve a level of reduction and stabilization that is appropriate to the age of the child. The biomechanical principal of the Titanium elastic nailing is based on the symmetrical bracing action of two elastic nails inserted into the metaphysis, each of which bears against the inner bone at three points. This was a prospective longitudinal study done over a period of one year in children between 5-14 yrs age groups. The complication rates associated with Titanium elastic nailing have been reported to be minimal.
Introduction: Since last two decades there has been growing trends towards a more operative treatment in patient over 7 years of age for long bone fractures (Tibia, Femur, Humerus) Method: Twenty patients (13 boys and 7 girls) aged between 7 to 14 of fractures of Tibia, Femur and Humerus treated with enders nail All patient underwent surgery in 7-8 days of injury Result: All patients followed average 2-4 weeks radiological union in 8-10 weeks and full weight bearing possible after 2-3 weeks Results:Excellent 75% Good 20% Poor 5% Conclusion: Enders nailing is effective form of treatment in long bone fractures (Diaphyseal) Tibia, Femur and Humerus in age between 7-14 years in Rural population.
Giant cell tumor of the bone (GCTB) is a benign bone tumor that can occasionally progress to malignancy, usually in chronic cases. It is a common benign and aggressive bone tumor that affects patients aged between 20 and 45 years. The most common location is the knee joint. It manifests as a painless or occasionally painful swelling over the affected area. A case of giant cell tumor (GCT) of the proximal tibia in a 72-year-old male is reported here, which was difficult to diagnose as it is rarely found in the geriatric age group. The patient came with a chief complaint of pain and swelling over his left knee for two months with a history of trauma to the knee a couple of times. On clinical examination, the patient had grade 3 tenderness and swelling on the anterolateral aspect of the knee extending toward the proximal tibia. The swelling was well-defined, smooth, firm, and uniform in consistency with dimensions of 15 cm × 12 cm. The swelling was moveable sideways, and the movement of the knee suggested that it was not attached to the underlying bone. As per the age and history of the rapid-growing lesion, we suspected malignancy, but clinical findings were pointing toward benign tumor. X-ray of the affected knee was done, which revealed a soft tissue mass with the involvement of the bone. Magnetic resonance imaging (MRI) of the knee revealed a soft tissue mass with the cortical breach. An open biopsy was done for the confirmation of the diagnosis, which was later reported and confirmed as a giant cell tumor of the proximal tibia. As bone tumor is associated with a cortical breach and pathological fracture, it was classified under Campanacci grade 3, for which an en bloc resection and open reduction and internal fixation with plate osteosynthesis with bone cementing and bone grafting were done followed by knee bending physiotherapy and gradual weight-bearing. Finally, the knee function was improved with pain relief.
Giant cell tumors (GCTs) are rare, benign, and locally invasive tumors, typically found in the epiphysis of long bones, most commonly at the distal femur and proximal tibia. To date, GCTs of the distal end of the ulna have been very rare. We document a case of a 38-year-old female with a distal ulna GCT, managed with en-bloc resection of the tumor with flexor carpi ulnaris and extensor carpi ulnaris tendon stabilization. The main aim of the GCT treatment is to prevent local recurrence and to maintain the function of the limb. Physical therapy was also given to the patient which helped in relieving pain, reducing edema, and increasing strength and range of motion. The patient was able to perform activities of daily living with the help of physical therapies and exercises. More research is needed to determine if broad excision of the distal ulna alone is a successful therapy for primary bone cancers affecting the distal ulna, including GCTs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.